Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $51.040M Est
Benzinga Newsdesk 10 hours ago
NewsGuidance
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.
Aquestive Therapeutics (NASDAQ:AQST) affirms FY2026 sales outlook from $46.000 million-$50.000 million to $46.000 million-$50.000 million vs $51.040 million estimate.